Hints and tips:
Related Special Reports
...a lawyer at The Basile Law Firm, who has used New York state usury laws to void several small-company financing deals....
...The company also pulled its 2025 target of adjusted earnings of $37 a share. Humana warned investors last week that higher costs were becoming a problem....
...Humana now expects diluted earnings to be $20 a share for the year ended December 31 2023, down from previous guidance of $26.31 a share....
...The latest number was unchanged from the government’s forecast in January, dashing hopes of an earnings boost for companies servicing that segment....
...A combination between Cigna and Humana would help the companies compete with larger rivals such as UnitedHealth Group and Elevance Health, formerly known as Anthem....
...Humana, with significant exposure to Medicare Advantage, was the biggest loser in the S&P 500. Its 13.4 per cent drop on Tuesday represented its third-biggest one-day fall of the past decade....
...Humana warned that costs were rising across the industry as people used more health services. Its shares have fallen more than a fifth since the start of the year....
...Seventy per cent of healthcare companies expect M&A activity in healthcare to increase in 2024 after two relatively quiet years, according to a recent global survey from Jefferies....
...A combined Cigna and Humana would help the companies compete with larger rivals including UnitedHealth Group and Elevance Health....
...US health insurer Cigna has abandoned plans to merge with Humana, a blockbuster transaction that would have created a $140bn insurance company, according to people familiar with the matter....
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...J&J was valued at $367bn, as of market close in New York on Thursday....
...Shares of UnitedHealth Group fell 6.3 per cent after rival health insurer Humana said it expects the industry wide trend of high medical costs to become a permanent phenomena, and delivered a grim earnings...
...Share moves to note on the New York Stock Exchange include Macy’s, Cigna, and Tesla: Macy’s surged 20 per cent following reports the department store operator was the subject of a potential $5.8bn buyout...
...Health insurer Humana and its rival UnitedHealth were also among the largest fallers....
...Tirzepatide is part of a new class of weight-loss drugs, known as GLP-1s, which includes Novo Nordisk’s Wegovy and Ozempic drugs, that are projected to expand to a $100bn market by the end of the decade,...
...The rise and fall of WeightWatchers Sistani describes the new WW as a judgment-free “weight health” company embracing “a full spectrum of solutions”....
...Companies jostling to take advantage of this shift are driving a new wave of mergers and acquisitions in the healthcare industry....
...Several of the bank’s businesses — including credit cards and corporate transaction services — did better than expected in a quarter that many thought would be marred by the upheaval of the restructuring...
...The stock closed at $50.44 after trading began on Thursday at the New York Stock Exchange under the ticker RDDT, up 48 per cent from its IPO price of $34 a share....
...An IPO could happen as early as late July as the company looks to cash in on investor excitement about the next generation of weight-loss drugs and a revival in the biotech IPO market....
...New York Community Bancorp shares shed a quarter of their value on Friday after the regional lender disclosed it had replaced its chief executive and identified “material weaknesses” in internal controls...
...Social media platform Reddit has picked the New York Stock Exchange as the venue for its long-delayed stock market debut, according to two people familiar with the plans, a victory for the exchange in its...
...Many of the businesses now underwrite their own debt deals, lending either directly to companies or against a host of assets....
...ESG Shareholder proposals Citigroup agrees to disclose green financing ratio Despite the backlash to environmental and social shareholder proposals, the New York City comptroller Brad Lander — who oversees...
International Edition